InspireMD Inc (NSPR.A) Quote| Reuters.com
Edition:
United States

InspireMD Inc (NSPR.A)

NSPR.A on American Stock Exchange

0.35USD
30 Jun 2016
Change (% chg)

$-0.01 (-4.11%)
Prev Close
$0.37
Open
$0.35
Day's High
$0.35
Day's Low
$0.35
Volume
4,531
Avg. Vol
12,107
52-wk High
$3.20
52-wk Low
$0.31

NSPR.A

Chart for NSPR.A

About

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its... (more)

Overall

Beta: 0.84
Market Cap(Mil.): $3.91
Shares Outstanding(Mil.): 10.72
Dividend: --
Yield (%): --

Financials

  NSPR.A Industry Sector
P/E (TTM): -- 41.77 35.71
EPS (TTM): -1.68 -- --
ROI: -350.34 11.63 14.23
ROE: -1,304.72 13.66 15.43

BRIEF-InspireMD amends loan & security agreement with Hercules Capital

* InspireMD announces amendment to loan & security agreement with Hercules Capital

Jun 14 2016

BRIEF-InspireMD Names Dr. James Barry as President and CEO

* James Barry replaces Alan Milinazzo, who previously announced decision to step down as director, president and CEO in January 2016

Jun 07 2016

BRIEF-InspireMD's cguard highlighted at late-breaking clinical trial session

* Breaking clinical trial session at the europcr 2016 conference Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 17 2016

BRIEF-InspireMD Q1 loss per share $0.32

* InspireMD reports financial results for the first quarter ended March 31, 2016

May 10 2016

BRIEF-Sol Barer reports 18.14 pct stake in Inspiremd

* Sol J. Barer reports a 18.14% pct stake in Inspiremd Inc as of March 9, 2015 - SEC filing

Apr 20 2016

BRIEF-Inspiremd Q4 non-gaap loss per share $0.31

* Inspiremd reports financial results for the fourth quarter and year ended december 31, 2015

Mar 28 2016

BRIEF-InspireMD announces pricing of public offering

* pricing of an public offering of 1.9 million shares of its common stock and warrants to purchase up to 950,000 shares of common stock

Mar 16 2016

BRIEF-Inspiremd announces proposed public offering of common stock and warrants

* Inspiremd announces proposed public offering of common stock and warrants

Mar 15 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.